Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I+ tumors | Proceedings of the National Academy of Sciences - pnas.org

[unable to retrieve full-text content]

Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I+ tumors | Proceedings of the National Academy of Sciences  pnas.org

Comments

Post a Comment

Popular posts from this blog

Creon: Dosage, side effects, alternatives, cost, uses, and more - Medical News Today

Image
Creon can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Creon. These lists do not include all possible side effects. For more information about the possible side effects of Creon, talk with your doctor or pharmacist. They can give you tips on how to deal with any side effects that may be bothersome. Note: The Food and Drug Administration (FDA) tracks side effects of drugs it has approved. If you would like to notify the FDA about a side effect you've had with Creon, you can do so through MedWatch. Mild side effects Mild side effects* of Creon can include: abnormal stools, such as having stools with a strange color, consistency, form, or smell dizziness frequent bowel movements gas high or low blood sugar levels sore throat, cough, or other cold symptoms abdominal (belly) pain vomiting Most of these side effects may go away within a few days or a couple of weeks. But if they become more severe or don't g...
Read more

Amring Pharmaceuticals Inc. Announces the Launch of Timolol ... - businesswire.com

Image
BERWYN, Pa.--( BUSINESS WIRE )--Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Timolol Maleate Ophthalmic Solution, USP 0.5%, 60 pack of 0.3mL unit dose vials (AT3 rated generic equivalent of Timoptic ® in Ocudose ® ) and has begun commercialization activities. Preservative-free Timolol Maleate Ophthalmic Solution, USP is supplied in single-dose vials, as a sterile, isotonic, buffered, aqueous solution of timolol maleate and is indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Preservative-free Timolol Maleate Ophthalmic Solution, USP in the unit dose vial may be used when a patient is sensitive to: the preservative in Timolol Maleate Ophthalmic Solution, USP, benzalkonium chloride, or when the use of a preservative-free topical medication is advisable. "We are pleased to have a...
Read more